Literature DB >> 14690453

Critical cysteine residues for regulation of integrin alphaIIbbeta3 are clustered in the epidermal growth factor domains of the beta3 subunit.

Tetsuji Kamata1, Hironobu Ambo, Wilma Puzon-McLaughlin, Kenneth Khiem Tieu, Makoto Handa, Yasuo Ikeda, Yoshikazu Takada.   

Abstract

Chemical or enzymic reduction/oxidation of integrin cysteine residues (e.g. by reducing agents and protein disulphide isomerase) may be a mechanism for regulating integrin function. It has also been proposed that unique cysteine residues in the integrin beta3 subunit are involved in the regulation of alphaIIbbeta3. In the present study, we studied systematically the role of disulphide bonds in beta3 on the ligand-binding function of alphaIIbbeta3 by mutating individual cysteine residues of beta3 to serine. We found that the disulphide bonds that are critical for alphaIIbbeta3 regulation are clustered within the EGF (epidermal growth factor) domains. Interestingly, disrupting only a single disulphide bond in the EGF domains was enough to activate alphaIIbbeta3 fully. In contrast, only two (of 13) disulphide bonds tested outside the EGF domains activated alphaIIbbeta3. These results suggest that the disulphide bonds in the EGF domains should be intact to keep alphaIIbbeta3 in an inactive state, and that there is no unique cysteine residue in the EGF domain critical for regulating the receptor. The cysteine residues in the EGF domains are potential targets for chemical or enzymic reduction.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14690453      PMCID: PMC1224037          DOI: 10.1042/BJ20031701

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Probing chemical and conformational differences in the resting and active conformers of platelet integrin alpha(IIb)beta(3).

Authors:  B Yan; D D Hu; S K Knowles; J W Smith
Journal:  J Biol Chem       Date:  2000-03-10       Impact factor: 5.157

2.  Crystal structure of the extracellular segment of integrin alpha Vbeta3.

Authors:  J P Xiong; T Stehle; B Diefenbach; R Zhang; R Dunker; D L Scott; A Joachimiak; S L Goodman; M A Arnaout
Journal:  Science       Date:  2001-09-06       Impact factor: 47.728

3.  Disruption of the long-range GPIIIa Cys(5)-Cys(435) disulfide bond results in the production of constitutively active GPIIb-IIIa (alpha(IIb)beta(3)) integrin complexes.

Authors:  Qi-Hong Sun; Chao-Yan Liu; Ronggang Wang; Cathy Paddock; Peter J Newman
Journal:  Blood       Date:  2002-09-15       Impact factor: 22.113

Review 4.  Integrin activation and structural rearrangement.

Authors:  Junichi Takagi; Timothy A Springer
Journal:  Immunol Rev       Date:  2002-08       Impact factor: 12.988

5.  A redox site involved in integrin activation.

Authors:  B Yan; J W Smith
Journal:  J Biol Chem       Date:  2000-12-22       Impact factor: 5.157

6.  Mechanism of integrin activation by disulfide bond reduction.

Authors:  B Yan; J W Smith
Journal:  Biochemistry       Date:  2001-07-31       Impact factor: 3.162

7.  Probing conformational changes in the I-like domain and the cysteine-rich repeat of human beta 3 integrins following disulfide bond disruption by cysteine mutations: identification of cysteine 598 involved in alphaIIbbeta3 activation.

Authors:  P Chen; C Melchior; N H Brons; N Schlegel; J Caen; N Kieffer
Journal:  J Biol Chem       Date:  2001-08-15       Impact factor: 5.157

8.  Disruption of a long-range disulfide bond between residues Cys406 and Cys655 in glycoprotein IIIa does not affect the function of platelet glycoprotein IIb-IIIa.

Authors:  R Wang; J Peterson; R H Aster; P J Newman
Journal:  Blood       Date:  1997-08-15       Impact factor: 22.113

9.  A point mutation in the cysteine-rich domain of glycoprotein (GP) IIIa results in the expression of a GPIIb-IIIa (alphaIIbbeta3) integrin receptor locked in a high-affinity state and a Glanzmann thrombasthenia-like phenotype.

Authors:  C Ruiz; C Y Liu; Q H Sun; M Sigaud-Fiks; E Fressinaud; J Y Muller; P Nurden; A T Nurden; P J Newman; N Valentin
Journal:  Blood       Date:  2001-10-15       Impact factor: 22.113

10.  Redox control of platelet aggregation.

Authors:  David W Essex; Mengru Li
Journal:  Biochemistry       Date:  2003-01-14       Impact factor: 3.162

View more
  25 in total

1.  Identification of integrin beta subunit mutations that alter heterodimer function in situ.

Authors:  Alison L Jannuzi; Thomas A Bunch; Robert F West; Danny L Brower
Journal:  Mol Biol Cell       Date:  2004-06-11       Impact factor: 4.138

2.  Modulation of integrin activation by an entropic spring in the {beta}-knee.

Authors:  Benoit J Smagghe; Po-Ssu Huang; Yih-En Andrew Ban; David Baker; Timothy A Springer
Journal:  J Biol Chem       Date:  2010-07-28       Impact factor: 5.157

3.  Unique disulfide bonds in epidermal growth factor (EGF) domains of β3 affect structure and function of αIIbβ3 and αvβ3 integrins in different manner.

Authors:  Ronit Mor-Cohen; Nurit Rosenberg; Yulia Einav; Ehud Zelzion; Meytal Landau; Wissam Mansour; Yulia Averbukh; Uri Seligsohn
Journal:  J Biol Chem       Date:  2012-02-03       Impact factor: 5.157

4.  Identification of integrin beta subunit mutations that alter affinity for extracellular matrix ligand.

Authors:  Timmy Kendall; Leona Mukai; Alison L Jannuzi; Thomas A Bunch
Journal:  J Biol Chem       Date:  2011-07-11       Impact factor: 5.157

5.  The novel S527F mutation in the integrin beta3 chain induces a high affinity alphaIIbbeta3 receptor by hindering adoption of the bent conformation.

Authors:  Karen Vanhoorelbeke; Simon F De Meyer; Inge Pareyn; Chantal Melchior; Sebastien Plançon; Christiane Margue; Olivier Pradier; Pierre Fondu; Nelly Kieffer; Timothy A Springer; Hans Deckmyn
Journal:  J Biol Chem       Date:  2009-03-27       Impact factor: 5.157

6.  The beta-tail domain (betaTD) regulates physiologic ligand binding to integrin CD11b/CD18.

Authors:  Vineet Gupta; Annette Gylling; José Luis Alonso; Takashi Sugimori; Petre Ianakiev; Jiang-Ping Xiong; M Amin Arnaout
Journal:  Blood       Date:  2006-12-14       Impact factor: 22.113

7.  C560Rβ3 caused platelet integrin αII b β3 to bind fibrinogen continuously, but resulted in a severe bleeding syndrome and increased murine mortality.

Authors:  J Fang; P Nurden; P North; A T Nurden; L M Du; N Valentin; D A Wilcox
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 8.  Control of blood proteins by functional disulfide bonds.

Authors:  Diego Butera; Kristina M Cook; Joyce Chiu; Jason W H Wong; Philip J Hogg
Journal:  Blood       Date:  2014-02-12       Impact factor: 22.113

9.  A point mutation in the EGF-4 domain of β(3) integrin is responsible for the formation of the Sec(a) platelet alloantigen and affects receptor function.

Authors:  Ulrich J Sachs; Tamam Bakchoul; Olga Eva; Astrid Giptner; Gregor Bein; Richard H Aster; Maria Gitter; Julie Peterson; Sentot Santoso
Journal:  Thromb Haemost       Date:  2011-11-24       Impact factor: 5.249

Review 10.  Redox-relevant aspects of the extracellular matrix and its cellular contacts via integrins.

Authors:  Johannes A Eble; Flávia Figueiredo de Rezende
Journal:  Antioxid Redox Signal       Date:  2014-01-08       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.